You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dolutegravir

Showing 1 - 25 of 330
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

HIV Trial (Dolutegravir/Rilpivirine FDC)

Not yet recruiting
  • HIV Infections
  • Dolutegravir/Rilpivirine FDC
  • (no location specified)
Jan 5, 2023

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Tenofovir alafenamide
  • Dolutegravir
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

Active, not recruiting
  • HIV-1-infection
  • Dolutegravir
  • Butha-Buthe, Lesotho
  • +1 more
Oct 23, 2022

Hiv Trial in Cape Town (Dolutegravir)

Recruiting
  • Hiv
  • Dolutegravir
  • Cape Town, Western Cape, South Africa
    Tygerberg Hospital
Oct 18, 2022

Tuberculosis, HIV Trial (Dolutegravir, 3HP)

Not yet recruiting
  • Tuberculosis
  • HIV
  • (no location specified)
Dec 9, 2022

HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

Not yet recruiting
  • HIV Infection
  • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
  • (no location specified)
Aug 8, 2023

Eswatini After Transition To Dolutegravir-Based Treatment

Recruiting
  • Neural Tube Defects
  • +2 more
    • Lubombo, Swaziland
    • +4 more
    May 22, 2023

    Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

    Completed
    • Malaria
    • Belfast, Northern Ireland, United Kingdom
      Novartis Investigative Site
    Nov 2, 2022

    AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

    Not yet recruiting
    • Acquired Immunodeficiency Syndrome
    • Dolutegravir 50 MG plus lamivudine 300 MG； Dolutegravir/lamivudine (50 MG/300 MG)
    • (no location specified)
    Aug 6, 2022

    Dolutegravir Trial in Johannesburg (CHARACTERISE)

    Enrolling by invitation
    • Dolutegravir
    • CHARACTERISE
    • Johannesburg, Gauteng, South Africa
      Sunnyside Office Park
    Aug 12, 2022

    HIV-1-infection, Pregnancy Related Trial in Cape Town, Kampala (Dolutegravir, Standard of Care (EFV + 2 NRTI backbone))

    Active, not recruiting
    • HIV-1-infection
    • Pregnancy Related
    • Dolutegravir
    • Standard of Care (EFV + 2 NRTI backbone)
    • Cape Town, Western Cape, South Africa
    • +1 more
    Aug 8, 2022

    HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,

    Not yet recruiting
    • HIV-associated Tuberculosis
    • Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
    • +3 more
    • Mowbray, Cape Town, Western Cape, South Africa
    • +3 more
    Nov 18, 2022

    HIV-1-infection Trial in Liège (Dolutegravir 50 MG)

    Recruiting
    • HIV-1-infection
    • Dolutegravir 50 MG
    • Liège, Belgium
      Liège university hospital
    Apr 27, 2022

    HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))

    Active, not recruiting
    • HIV Infections
    • Treatment simplification (dolutegravir lamivudine)
    • Liège, Belgium
      Liège university hospital
    Apr 27, 2022

    HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

    Not yet recruiting
    • HIV
    • HIV Infections
    • Dolutegravir
    • +4 more
    • (no location specified)
    Aug 4, 2023

    HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

    Active, not recruiting
    • HIV I Infection
    • Dolutegravir / Lamivudine Pill
    • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
    • Orlando, Florida
      Orlando Immunology Center
    Sep 20, 2022

    Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo

    Recruiting
    • Human Immunodeficiency Virus
    • +2 more
    • Dolutegravir
    • +2 more
    • Gaborone, Botswana
      Princess Marina Hospital
    Mar 1, 2022

    HIV-1-infection Trial in Argentina, Brazil (Intervention Arm: dolutegravir/lamivudine, Comparator ARM: TDF/XTC plus Dolutegravir

    Recruiting
    • HIV-1-infection
    • Intervention Arm: dolutegravir/lamivudine
    • Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
    • Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
    • +7 more
    Jun 29, 2022

    HIV Trial in Worldwide (Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate

    Recruiting
    • HIV Infections
    • Dolutegravir film-coated tablets
    • +3 more
    • Los Angeles, California
    • +16 more
    Sep 29, 2022

    HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg

    Completed
    • HIV-1-infection
    • abacavir, dolutegravir and lamivudine dispersible tablets
    • Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
    • Montréal, Quebec, Canada
      Altasciences
    Mar 10, 2022

    Tolerability of Lopinavir Versus Dolutegravir for Children and

    Recruiting
    • HIV
      • Maseru, Lesotho
      • +1 more
      Jul 25, 2022

      Dolutegravir Use in Human Immunodeficiency Virus Positive

      Recruiting
      • HIV Infections
      • Barcelona, Spain
        GSK Investigational Site
      Jul 21, 2022

      HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)

      Withdrawn
      • HIV-1 Infection
      • Dolutegravir plus lamivudine
      • Caba, Buenos Aires, Argentina
      • +1 more
      Apr 5, 2022